Prenatal Care Practice Questions

Q: A 28-year-old woman at 10 weeks of gestation presents with severe vomiting, weight loss, and ketonuria. What is the most likely diagnosis?

Hyperemesis gravidarum. ***Hyperemesis gravidarum*** - Characterized by **severe nausea and vomiting** during pregnancy, typically in the **first trimester**, leading to **weight loss >5% of pre-pregnancy weight** and **ketonuria**. - It is distinct from typical morning sickness due to its severity and metabolic disturbances (dehydration, electrolyte imbalance, ketosis). - Most cases resolve by 20 weeks of gestation. *Gastroenteritis* - While it causes vomiting and may lead to ketonuria, it is typically an **acute, self-limiting viral or bacterial infection** lasting days, not weeks. - It would not typically present as a chronic condition causing significant weight loss over an extended period in pregnancy. - Usually accompanied by **diarrhea**, which is not mentioned in this case. *Preeclampsia* - This condition is characterized by **new-onset hypertension and proteinuria** after 20 weeks of gestation. - At **10 weeks gestation**, it is too early for preeclampsia to develop. - Vomiting can occur in severe cases, but it's not the primary symptom, and weight loss and ketonuria are not typical diagnostic features. *Gestational diabetes* - This involves **glucose intolerance** that develops or is first recognized during pregnancy, typically diagnosed at **24-28 weeks**. - Symptoms usually include **polyuria, polydipsia, and fatigue**, not severe vomiting, weight loss, or ketonuria. - Ketonuria in diabetes suggests ketoacidosis, which would present with hyperglycemia, not the clinical picture described.

Q: A 29-year-old woman with a history of preeclampsia in a previous pregnancy presents at 12 weeks of gestation. What is the recommended prophylactic treatment?

Aspirin. ***Aspirin*** - **Low-dose aspirin** is recommended for women with a history of preeclampsia, especially when started early in pregnancy (before 16 weeks of gestation). - It helps reduce the risk of recurrent preeclampsia by improving **placental perfusion** and inhibiting platelet aggregation. *Calcium supplements* - While recommended for women with **low dietary calcium intake**, calcium supplementation alone does not have the same strong evidence for prophylactic preeclampsia prevention as aspirin. - It's often used as an adjunct in high-risk pregnancies, but not typically as the primary prophylactic agent in this specific scenario. *Methyldopa* - **Methyldopa** is an **antihypertensive medication** used to treat existing hypertension in pregnancy. - It does not serve as a primary prophylactic agent to prevent the development of preeclampsia in a woman with a history of the condition. *Labetalol* - **Labetalol** is another **antihypertensive medication** commonly used to manage acute or chronic hypertension during pregnancy. - Similar to methyldopa, it is a treatment for established hypertension rather than a prophylactic measure against preeclampsia recurrence.

Q: In the context of prenatal care, what is the significance of the double marker test?

It assesses the risk of Down syndrome.. ***It assesses the risk of Down syndrome.*** - The **double marker test** measures levels of **free beta-human chorionic gonadotropin (hCG)** and **pregnancy-associated plasma protein-A (PAPP-A)** in maternal blood. - Abnormal levels of these markers, particularly a **high hCG** and **low PAPP-A**, are indicative of an increased risk of **Down syndrome (Trisomy 21)**. *It detects neural tube defects.* - **Neural tube defects** are primarily screened for using **alpha-fetoprotein (AFP)** levels, often part of the quadruple screen or maternal serum screening. - The double marker test components (hCG and PAPP-A) are not reliable markers for neural tube defects. *It evaluates fetal lung maturity.* - **Fetal lung maturity** is typically assessed later in pregnancy, often through analysis of **amniotic fluid** for ratios like **lecithin-sphingomyelin (L/S ratio)** or presence of **phosphatidylglycerol**. - The double marker test is performed in the first trimester and does not provide information about fetal lung development. *It screens for gestational diabetes.* - **Gestational diabetes** screening is performed later in pregnancy, usually between **24 and 28 weeks**, using a **glucose challenge test** followed by an oral glucose tolerance test if necessary. - The double marker test biomarkers are unrelated to glucose metabolism or the screening for gestational diabetes.

Q: A pregnant woman at 14 weeks of gestation shows increased nuchal thickness on ultrasound. Which test is NOT included in the second trimester quadruple test for Down's syndrome?

PAPP-A. ***PAPP-A*** - **Pregnancy-associated plasma protein-A (PAPP-A)** is a marker included in the **first-trimester screening** for Down syndrome, primarily performed between weeks 10 and 14 of gestation. - The question specifies the **second-trimester quadruple screen**, therefore, PAPP-A is **NOT part of this test**. - This is the **correct answer** as it is the only marker listed that is NOT included in the second-trimester quadruple test. *AFP* - **Alpha-fetoprotein (AFP)** is one of the four markers measured in the **quadruple screen** during the second trimester. - Low levels of AFP, combined with other markers, can indicate an increased risk of **Down syndrome**. *hCG* - **Human chorionic gonadotropin (hCG)** is another marker included in the **second-trimester quadruple screen**. - **Elevated levels of hCG** are associated with an increased risk for Down syndrome. *Inhibin A* - **Inhibin A** is the fourth marker in the **quadruple screen**, alongside AFP, hCG, and **unconjugated estriol (uE3)**. - **Elevated levels of Inhibin A** in the second trimester are suggestive of an increased risk of Down syndrome. **Note:** The complete second-trimester quadruple screen includes: AFP, hCG, unconjugated estriol (uE3), and Inhibin A. PAPP-A is used only in first-trimester screening.

Q: During a routine prenatal visit, a 25-year-old woman at 18 weeks of gestation is found to have a low-lying placenta. What is the most appropriate management?

Schedule for a repeat ultrasound at 28 weeks. ***Schedule for a repeat ultrasound at 28 weeks*** - A **low-lying placenta** at 18 weeks is common, and in most cases, the placenta will "migrate" away from the cervix as the uterus grows. - A repeat ultrasound at **28 weeks (or later)** is necessary to assess whether the placenta has moved to a safe position for vaginal delivery or if it remains a **placenta previa**. *Immediate cesarean delivery due to complications* - **Cesarean delivery** is not indicated at 18 weeks based solely on a low-lying placenta, as it is a common finding that usually resolves. - Complications warranting immediate delivery, such as **severe bleeding** or **fetal distress**, are not mentioned here. *Bed rest until further evaluation* - **Bed rest** is generally not recommended for an uncomplicated low-lying placenta at this gestation, as it lacks evidence for efficacy and carries risks. - It might be considered in cases of **vaginal bleeding** with placenta previa, but not as a routine measure for this finding. *Initiate corticosteroids for fetal lung maturity* - **Corticosteroids** are given to accelerate **fetal lung maturity** in cases of anticipated preterm birth, typically before 34-37 weeks. - There is no indication of impending **preterm delivery** or other complications requiring corticosteroids at 18 weeks.

Q: What is the gold standard diagnostic procedure for assessing placental location during the second trimester?

Transvaginal ultrasound imaging. ***Transvaginal ultrasound imaging*** - The **gold standard for accurate assessment** of placental location, particularly for determining the exact distance between the placental edge and the internal cervical os. - Provides **superior resolution and clarity** of the cervix and lower uterine segment compared to transabdominal approach, with sensitivity approaching **95-100%** for placenta previa diagnosis. - Particularly valuable when the placenta is **posterior**, in **obese patients**, or when transabdominal findings are equivocal. - **Safe procedure** with no increased risk of bleeding, contrary to historical concerns. *Transabdominal ultrasound imaging* - The standard **initial screening tool** for placental localization in routine second-trimester anatomy scans. - May provide **suboptimal visualization** of the lower uterine segment, especially with a posterior placenta, full bladder distortion, or maternal obesity. - Can **overestimate** the distance between placental edge and cervical os due to bladder compression effects, potentially leading to false-positive diagnoses of placenta previa that resolve on transvaginal imaging. *Computed Tomography (CT) scan* - Involves **ionizing radiation** exposure to the fetus, which is contraindicated in pregnancy except for emergent maternal indications. - Provides **poor soft tissue contrast** for placental assessment compared to ultrasound. - Not used for routine obstetric imaging. *Magnetic Resonance Imaging (MRI)* - Excellent soft tissue contrast but **more expensive**, time-consuming, and less readily available than ultrasound. - Reserved for **complex scenarios** such as suspected placenta accreta spectrum disorders, morbidly adherent placenta, or when ultrasound findings are inconclusive. - Not the primary modality for routine placental localization in the second trimester.

Q: What is the recommended daily dose of folic acid supplementation for pregnant women according to current Indian guidelines?

500 micrograms daily. ***500 micrograms daily*** - This is the **recommended dose** according to **ICMR-NIN (2020)** and **FOGSI guidelines** for pregnant women in India. - **WHO recommends 400-800 mcg daily**, and 500 mcg falls within this evidence-based range. - This dose effectively **prevents neural tube defects** (NTDs) like spina bifida and anencephaly when taken periconceptionally and during early pregnancy. - Should be started **at least one month before conception** and continued through the first trimester. *400 micrograms daily* - This was the older recommended dose and is still acceptable as per some international guidelines (USPSTF, older ACOG recommendations). - However, **current Indian guidelines specifically recommend 500 mcg** as the standard dose for the Indian population. - Still within the effective range but not the specific Indian recommendation. *200 micrograms daily* - This dose is **insufficient** for effective prevention of neural tube defects during pregnancy. - Does not meet the **increased folate demands** during pregnancy for DNA synthesis and fetal development. *800 micrograms daily* - This is at the **upper end of the WHO recommended range** (400-800 mcg). - While not harmful and still within safe limits, it is **higher than the standard Indian recommendation** of 500 mcg. - High-dose folic acid (4-5 mg daily) is reserved for **high-risk women** with previous NTD-affected pregnancy, diabetes, or on anticonvulsants.

Q: A 35-year-old woman at 12 weeks of gestation presents with severe nausea and vomiting, weight loss, and dehydration. What is the diagnosis?

Hyperemesis gravidarum. ***Hyperemesis gravidarum*** - This condition is characterized by **severe, persistent nausea and vomiting** during pregnancy, often leading to **weight loss** and **dehydration**. - It typically begins in the first trimester, peaking around 9-13 weeks, consistent with the patient's 12 weeks gestation. *Preeclampsia* - Preeclampsia usually manifests after **20 weeks of gestation** with symptoms like **hypertension**, **proteinuria**, and sometimes edema, which are not described here. - While preeclampsia can cause vomiting in severe cases, the primary symptoms are blood pressure and kidney-related. *Acute fatty liver of pregnancy* - This is a rare and severe liver disorder that typically occurs in the **third trimester** of pregnancy. - It presents with symptoms like nausea, vomiting, abdominal pain, and jaundice, but the timing is inconsistent with this patient's presentation. *Gastroenteritis* - While gastroenteritis causes nausea, vomiting, and dehydration, it is typically an **acute, self-limiting infection** and wouldn't be specifically tied to the pregnancy itself without further evidence of infection. - The severity and chronicity suggested by "severe nausea and vomiting" and "weight loss" are more indicative of hyperemesis gravidarum in a pregnant woman.

Q: Which medication is preferred for treating urinary tract infections in pregnant women during the second trimester: nitrofurantoin or trimethoprim-sulfamethoxazole?

Nitrofurantoin is preferred.. ***Nitrofurantoin is preferred.*** - **Nitrofurantoin** is generally considered safe and effective for treating UTIs during the **second trimester** of pregnancy. - Its use avoids the risks associated with other antibiotics during earlier or later stages of pregnancy. *Both are equally effective.* - While both can be effective against common UTI pathogens, their **safety profiles differ significantly** during pregnancy. - **Trimethoprim-sulfamethoxazole** carries specific risks during pregnancy that make it less preferred. *Neither is recommended.* - Untreated UTIs in pregnancy can lead to serious complications such as **pyelonephritis**, **preterm labor**, and **low birth weight**. - Appropriate antibiotic treatment is crucial and recommended to prevent such adverse outcomes. *Trimethoprim-sulfamethoxazole is preferred.* - **Trimethoprim** is a **folate antagonist**, posing a risk of **neural tube defects** in the first trimester. - **Sulfamethoxazole** can displace **bilirubin** from albumin, increasing the risk of **kernicterus** in the third trimester, making it generally avoided in later pregnancy as well.

Q: What is the recommended daily intake of folic acid during the first trimester of normal pregnancy?

400-500 micrograms. ***400-500 micrograms*** - The recommended daily intake of **folic acid** for women during their first trimester of pregnancy is **400-500 micrograms**. - This dosage helps prevent **neural tube defects** (NTDs) in the developing fetus, as the neural tube forms early in pregnancy. *100 micrograms* - This dosage is **insufficient** for preventing neural tube defects during pregnancy. - A lower dose may be adequate for general health but does not meet the increased demands during early pregnancy. *4 milligrams* - This dosage is significantly **higher** than the standard recommendation for an uncomplicated pregnancy. - Such a high dose (4 mg or 4000 micrograms) is typically reserved for women with a **history of a previous pregnancy affected by a neural tube defect**, indicating a higher risk. *5 milligrams* - Similar to 4 milligrams, this dosage (5000 micrograms) is also considered a **high dose**. - It is usually prescribed for women with **specific risk factors** for neural tube defects, such as a family history or certain medical conditions, rather than for a normal, uncomplicated pregnancy.

Question 1

A 28-year-old woman at 10 weeks of gestation presents with severe vomiting, weight loss, and ketonuria. What is the most likely diagnosis?

Accepted Answer

Hyperemesis gravidarum

Answer

Gastroenteritis

Answer

Preeclampsia

Answer

Gestational diabetes

Question 2

A 29-year-old woman with a history of preeclampsia in a previous pregnancy presents at 12 weeks of gestation. What is the recommended prophylactic treatment?

Accepted Answer

Aspirin

Answer

Calcium supplements

Answer

Methyldopa

Answer

Labetalol

Question 3

In the context of prenatal care, what is the significance of the double marker test?

Accepted Answer

It assesses the risk of Down syndrome.

Answer

It detects neural tube defects.

Answer

It evaluates fetal lung maturity.

Answer

It screens for gestational diabetes.

Question 4

A pregnant woman at 14 weeks of gestation shows increased nuchal thickness on ultrasound. Which test is NOT included in the second trimester quadruple test for Down's syndrome?

Accepted Answer

PAPP-A

Answer

hCG

Answer

Inhibin A

Answer

AFP

Question 5

During a routine prenatal visit, a 25-year-old woman at 18 weeks of gestation is found to have a low-lying placenta. What is the most appropriate management?

Accepted Answer

Schedule for a repeat ultrasound at 28 weeks

Answer

Immediate cesarean delivery due to complications

Answer

Initiate corticosteroids for fetal lung maturity

Answer

Bed rest until further evaluation

Question 6

What is the gold standard diagnostic procedure for assessing placental location during the second trimester?

Accepted Answer

Transvaginal ultrasound imaging

Answer

Transabdominal ultrasound imaging

Answer

Computed Tomography (CT) scan

Answer

Magnetic Resonance Imaging (MRI)

Question 7

What is the recommended daily dose of folic acid supplementation for pregnant women according to current Indian guidelines?

Accepted Answer

500 micrograms daily

Answer

400 micrograms daily

Answer

200 micrograms daily

Answer

800 micrograms daily

Question 8

A 35-year-old woman at 12 weeks of gestation presents with severe nausea and vomiting, weight loss, and dehydration. What is the diagnosis?

Accepted Answer

Hyperemesis gravidarum

Answer

Acute fatty liver of pregnancy

Answer

Preeclampsia

Answer

Gastroenteritis

Question 9

Which medication is preferred for treating urinary tract infections in pregnant women during the second trimester: nitrofurantoin or trimethoprim-sulfamethoxazole?

Accepted Answer

Nitrofurantoin is preferred.

Answer

Both are equally effective.

Answer

Neither is recommended.

Answer

Trimethoprim-sulfamethoxazole is preferred.

Question 10

What is the recommended daily intake of folic acid during the first trimester of normal pregnancy?

Accepted Answer

400-500 micrograms

Answer

100 micrograms

Answer

4 milligrams

Answer

5 milligrams

Prenatal Care — MCQs

Prenatal Care — MCQs

On this page

Practice by Chapter

Want unlimited practice?